E9 Genomics

United States
Primghar, Iowa, United States, 02141

Company profile

E9 Genomics company profile

E9 Genomics focuses on computational genomics within the biotechnology and data science sectors. The company provides technologies and infrastructure to support scientists and clinicians in their genomic research. E9 Genomics aims to accelerate therapeutic research and precision medicine by enabling efficient querying and analysis of large genomic datasets.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2023-01-01, Year

Headquarters

Postal code
02141
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$150,000
Last funding
Pre Seed / $150,000 / 2023-10-01
Last equity funding
Pre Seed / $150,000
Investors
1

Founders and investors

Investors

Merck Digital Sciences Studio